To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and colchicine in patients with symptomatic primary biliary cirrhosis (PBC), defined by the presence of liver cirrhosis, pruritus or bilirubin exceeding 2 mg/mL
BACKGROUND and AIMS: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic liver dise...
Primary biliary cholangitis (PBC), previously known as primary biliary "cirrhosis", is a rare autoim...
textabstractPrimary Biliary Cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by...
Combined medical treatment may provide further benefit to primary biliary cirrhosis (PBC) patients a...
Abstract: Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and...
The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to humans, has b...
Abstract The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to hum...
Ursodeoxycholic acid is considered as first line treatment in patients with primary biliary cirrhosi...
One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based o...
To evaluate the effect of ursodeoxycholic acid (UDCA) treatment according to the severity of primary...
BACKGROUND: Ursodeoxycholic acid (UDCA) improves liver function tests and prolongs survival in prima...
Primary biliary cirrhosis (PBC) is an autoimmune disease. Ursodeoxycholic acid (UDCA) is the only sa...
Primary biliary cirrhosis (PBC) is a rare inflammatory liver disease for which ursodeoxycholic acid ...
textabstractBACKGROUND Primary biliary cholangitis (formerly called primary biliary cirrhosis) can p...
BACKGROUND Primary biliary cholangitis ( formerly called primary biliary cirrhosis) can progress to ...
BACKGROUND and AIMS: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic liver dise...
Primary biliary cholangitis (PBC), previously known as primary biliary "cirrhosis", is a rare autoim...
textabstractPrimary Biliary Cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by...
Combined medical treatment may provide further benefit to primary biliary cirrhosis (PBC) patients a...
Abstract: Aim: To establish the efficacy of combination therapy with ursodeoxycholic acid (UDCA) and...
The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to humans, has b...
Abstract The administration of ursodeoxycholic acid, a hydrophilic bile acid not hepatotoxic to hum...
Ursodeoxycholic acid is considered as first line treatment in patients with primary biliary cirrhosi...
One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based o...
To evaluate the effect of ursodeoxycholic acid (UDCA) treatment according to the severity of primary...
BACKGROUND: Ursodeoxycholic acid (UDCA) improves liver function tests and prolongs survival in prima...
Primary biliary cirrhosis (PBC) is an autoimmune disease. Ursodeoxycholic acid (UDCA) is the only sa...
Primary biliary cirrhosis (PBC) is a rare inflammatory liver disease for which ursodeoxycholic acid ...
textabstractBACKGROUND Primary biliary cholangitis (formerly called primary biliary cirrhosis) can p...
BACKGROUND Primary biliary cholangitis ( formerly called primary biliary cirrhosis) can progress to ...
BACKGROUND and AIMS: Ursodeoxycholic acid (UDCA) is used for the treatment of cholestatic liver dise...
Primary biliary cholangitis (PBC), previously known as primary biliary "cirrhosis", is a rare autoim...
textabstractPrimary Biliary Cirrhosis (PBC) is a chronic, cholestatic liver disease characterized by...